Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanomaPing Yuan, Koichi Ito, Rolando Perez-Lorenzo, et al.
Cancer Research|May 20, 2017
Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic ResponsesGeorg Karpel-Massler, Chiaki Tsuge Ishida, Elena Bianchetti, et al.
The FEBS Journal|August 19, 2011
The prion protein binds thiamineRolando Perez-Pineiro, Trent C Bjorndahl, Mark V Berjanskii, et al.
Molecular Pharmacology|April 13, 2013
Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cellsLars Petter Jordheim, Khaled H Barakat, Laurence Heinrich-Balard, et al.
Human Vaccines|September 22, 2010
Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patientsVladimir Mulens, Ana de la Torre, Patricia Marinello, et al.
Plos One|January 4, 2013
Liana abundance, diversity, and distribution on Barro Colorado Island, PanamaStefan A Schnitzer, Scott A Mangan, James W Dalling, et al.
Oncotarget|July 1, 2015
High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesisChun-yu Wang, Jia-ying Deng, Xu-wei Cai, et al.
Oncotargets and Therapy|November 16, 2013
Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trialJun Liang, Mingyan E, Gang Wu, et al.
Cancer Immunology, Immunotherapy : CII|January 9, 2022
Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanomaRobyn D Gartrell, Zoë Blake, Emanuelle M Rizk, et al.
Nucleic Acids Research|November 20, 2012
HMDB 3.0--The Human Metabolome Database in 2013David S Wishart, Timothy Jewison, An Chi Guo, et al.
Pageof 6